A platform for research: civil engineering, architecture and urbanism
A platform for research: civil engineering, architecture and urbanism
QUINAZOLINE ANALOGS AS RECEPTOR TYROSINE KINASE INHIBITORS
The invention includes methods of using compounds of Formula I as type I receptor tyrosine kinase inhibitors and for the treatment of hyperproliferative diseases such as cancer.
QUINAZOLINE ANALOGS AS RECEPTOR TYROSINE KINASE INHIBITORS
The invention includes methods of using compounds of Formula I as type I receptor tyrosine kinase inhibitors and for the treatment of hyperproliferative diseases such as cancer.
QUINAZOLINE ANALOGS AS RECEPTOR TYROSINE KINASE INHIBITORS
WALLACE ELI (author) / TOPALOV GEORGE (author) / LYSSIKATOS JOSEPH (author) / BUCKMELTER ALEXANDRE (author) / ZHAO QIAN (author)
2019-05-30
Patent
Electronic Resource
English
Quinazoline analogs as receptor tyrosine kinase inhibitors
| European Patent Office | 2019
QUINAZOLINE ANALOGS AS RECEPTOR TYROSINE KINASE INHIBITORS
| European Patent Office | 2017
QUINAZOLINE ANALOGS AS RECEPTOR TYROSINE KINASE INHIBITORS
| European Patent Office | 2021
Quinazoline analogs as receptor tyrosine kinase inhibitors
| European Patent Office | 2017
Signal Transduction by EGF Receptor Tyrosine Kinase
| British Library Conference Proceedings | 1997